Myeloid markers should be undertaken in cases of CD56 positivity to exclude granulocytic sarcoma. [electronic resource]
Producer: 20021122Description: 609-11 p. digitalISSN:- 0007-0963
No physical items for this record
Publication Type: Case Reports; Letter
There are no comments on this title.
Log in to your account to post a comment.